MedTrace Logo

Evaluation of the Pharmacokinetics of Prana P1 Capsules

NCT03744091 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2019-06-07

No results posted yet for this study

Summary

This is a single dose clinical trial to assess the Pharmacokinetics of two (2) dosages; 10 mg and 20mg of THC: THCa of Prana P1 bionutrients in healthy volunteers.

Conditions

  • Healthy

Interventions

DRUG

P1

10 mg or 20 mg of THC:THCa

Sponsors & Collaborators

  • The University of The West Indies

    lead OTHER

Principal Investigators

  • Marvin Reid, MBBS · Caribbean Institute for Health Research, University of the West Indies

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-16
Primary Completion
2019-01-23
Completion
2019-08-23

Countries

  • Jamaica

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03744091 on ClinicalTrials.gov